STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

JJ Qin, L Yan, J Zhang, WD Zhang - Journal of Experimental & Clinical …, 2019 - Springer
Triple negative breast cancer (TNBC), which is typically lack of expression of estrogen
receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 …

An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer

H Qayoom, NA Wani, B Alshehri, MA Mir - Future oncology, 2021 - Taylor & Francis
Triple-negative breast cancer (TNBC) is the most complex, aggressive and fatal subtype of
breast cancer. Owing to the lack of targeted therapy and heterogenic nature of TNBC …

Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies

WF Zuo, Q Pang, X Zhu, QQ Yang, Q Zhao… - Journal of Hematology & …, 2024 - Springer
Heat shock proteins are essential molecular chaperones that play crucial roles in stabilizing
protein structures, facilitating the repair or degradation of damaged proteins, and …

[HTML][HTML] The disruption of protein− protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition

MA Serwetnyk, BSJ Blagg - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Abstract The 90-kiloDalton (kD) heat shock protein (Hsp90) is a ubiquitous, ATP-dependent
molecular chaperone whose primary function is to ensure the proper folding of several …

Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization

F Gao, X Yu, M Li, L Zhou, W Liu, W Li, H Liu - Cell Death & Disease, 2020 - nature.com
Activating mutations of epidermal growth factor receptor (EGFR) play crucial roles in the
oncogenesis of human non-small cell lung cancer (NSCLC). By screening 79 commercially …

Pharmacological basis and new insights of deguelin concerning its anticancer effects

ZY Lin, QZ Yun, L Wu, TW Zhang, TZ Yao - Pharmacological Research, 2021 - Elsevier
Deguelin is a rotenoid of the flavonoid family, which can be extracted from Lonchocarpus,
Derris, or Tephrosia. It possesses the inhibition of cancer cell proliferation by inducing …

Liposomes modified with double-branched biotin: A novel and effective way to promote breast cancer targeting

R Lu, L Zhou, Q Yue, Q Liu, X Cai, W Xiao, L Hai… - Bioorganic & medicinal …, 2019 - Elsevier
Although active targeting liposomes with cancer-specific ligands can bind and internalize
into cancer cells, only a few high-efficiency liposomes have been developed so far because …

A silicon-containing aryl/penta-1, 4-dien-3-one/amine hybrid exhibits antiproliferative effects on breast cancer cells by targeting the HSP90 C-terminus without …

YT Liao, XY Du, M Wang, CX Zheng, D Li… - RSC Medicinal …, 2023 - pubs.rsc.org
A pharmacophore-hybridized strategy based on previously reported HSP90 C-terminal
inhibitors was utilized to prepare 32 aryl/penta-1, 4-dien-3-one/amine hybrids. Among them …

[HTML][HTML] Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic …

W Guo, Y Ding, C Pu, Z Wang, W Deng… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background Pancreatic cancer has a high degree of malignancy and high mortality.
Understanding its biological status can provide more therapeutic targets for the future. The …

Discovery of a simplified deguelin analog as an HSP90 C-terminal inhibitor for HER2-positive breast cancer

CT Nguyen, MT La, J Ann, G Nam, HJ Park… - Bioorganic & Medicinal …, 2021 - Elsevier
A series of O-substituted analogs of the C-ring-truncated scaffold of deguelin designed as
heat shock protein 90 (HSP90) C-terminal inhibitors were investigated as novel antitumor …